As part of an evidence-based addiction treatment program, comprehensive urine drug testing (UDT) can serve as a therapeutic tool in the assessment and management of patients across all phases of recovery from substance abuse disorders. Our unique approach to UDT is consistent with the American Society of Addiction Medicine’s national consensus statement recommending UDT to identify the presence of prescribed and approved medication taken as part of addiction recovery therapy, as well as illicit substances most commonly abused. Understanding which substances patients have ingested improves providers’ ability to determine the effectivity of the treatment plan and provide motivation or reinforcement for abstinence.
Laboratory Testing for Substance Use Disorders: Challenges and Case Studies
Friday, November 11, 8:45 a.m. – 9:15 a.m.
Virtual and in-person
Learning objectives
• Assess and treat addictive disorders with an emphasis on the newest information relevant to practicing addiction treatment professionals.
• Implications of co-morbid psychopathology on addiction recovery and new models of incorporation of psychologic and psychiatric interventions into primary and post-primary addiction treatment.
• Assessment techniques to novel psychosocial and pharmacologic treatment interventions.
Learn more about
Addiction rehabilitation monitoring
Controlled substance monitoring
Targeted testing for marijuana use
Targeted testing for opioid use
Digital resources
AACC Laboratory Medicine Practice Guidelines
Addiction rehab monitoring assay [Test in Focus]
New High-Resolution Targeted Opioid Screen
Laboratory Detection of Opioids
Printable documents
Pain Management Testing Services Overview
Controlled Substance Monitoring Brochure
Targeted Opioid Monitoring Flyer
Opioids Pharmacokinetics Chart